NEW YORK, Dec. 11 - MDS Proteomics on Tuesday has named Anil K. Amlani to be its chief financial officer.
According to the company, he will be responsible for "driving and maintaining further financial growth and development" and will report directly to Frank Gleeson, MDS Proteomics' president and CEO.
"Anil's financial expertise, his strong relationships with the investment and analyst community, and his established technology background will play an essential role in helping MDS Proteomics to determine financing opportunities, including the possibility of an IPO in 2002," Gleeson said in a statement.
"Anil will also assist us greatly in our ongoing negotiations with top-tier pharmaceutical and biotechnology companies concerning broad commercial collaborations," he added.
Before joining Toronto-based MDS Proteomics, Amlani was senior vice president and CFO of Cancom, Canadian Satellite Communications where he headed business planning and financing for all operating units and oversaw all principal investments.